TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/25 21:54 | 4/3/25 | HROW | Harrow, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Saharek John P. | TN | O | CEO,P,Im | M.d | 0 | 0.00 | 0 | 277 | 146 | 467 | D | ||||||||||||||
9/13/24 17:26 | 9/11/24 | HROW | Harrow, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Saharek John P. | TN | O | CEO of I | M.d | 663 | 7.37 | 0 | 90 | 43 | 300 | D | ||||||||||||||
3/6/24 06:06 | 3/1/24 | HROW | Harrow, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Saharek John P. | TN | O | CEO of I | M.d | 44 | 8.75 | 0 | 5 | 2 | 255 | D | ||||||||||||||
2/21/24 19:30 | 2/20/24 | HROW | Harrow, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Saharek John P. | TN | O | CEO of I | M.d | 455 | 10.67 | 0 | 43 | 21 | 250 | D | ||||||||||||||
11/14/23 19:02 | 11/10/23 | HROW | Harrow, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Saharek John P. | TN | O | Chief Co | M.d | 0 | 0.00 | 0 | 20 | 9 | 232 | D | ||||||||||||||
7/20/23 19:46 | 7/18/23 | HROW | Harrow Health, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Saharek John P. | TN | O | Chief Co | M.d | 0 | 0.00 | 0 | 277 | 222 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |